{"lc": {"ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds": {"story_link": "https://www.thepharmaletter.com/article/ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds", "user_code": "SAP_3", "age_group": "51_plus", "agreed": true, "close_date_time": "2021-9-26 16:39:44", "close_timestamp": 1635262784869, "created": "26/10/2021 15:37:24", "department": "computing", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-10-26", "gender": "female", "id": "4c9d3509-98e8-424c-872f-6d64c129886f", "open_date_time": "2021-9-26 16:35:43", "open_timestamp": 1635262543878, "story_date": "2020-04-21 00:00:00", "story_source": "tpl", "story_title": "Ivermectin can kill COVID-19 within 48 hours', Monash University study finds", "summary": "According to Dr Wagstaff, recent studies show that a new potential drug can kill covid in several hours. ", "task_condition": "viz", "task_key": "ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds", "task_level": "post_graduate_phd", "time_taken_in_seconds": 240991, "what": "a new discovery of potential drug against covid-19", "when_happened": "few_years_ago", "where_location": "University of Monash", "who": "Dr Wagstaff, he was interviewed", "why": "contributes to fighting covid"}, "challenges-expected-for-novavax-covid-19-vaccine-in-usa": {"story_link": "https://www.thepharmaletter.com/article/challenges-expected-for-novavax-covid-19-vaccine-in-usa", "user_code": "SAP_3", "age_group": "51_plus", "agreed": true, "close_date_time": "2021-9-26 16:48:5", "close_timestamp": 1635263285305, "created": "26/10/2021 15:45:45", "department": "computing", "disability": false, "ease": 4, "environment": "production", "experiment_date_datepicker": "2021-10-26", "gender": "female", "id": "89c988a4-8890-408a-a516-cfddd8279893", "open_date_time": "2021-9-26 16:43:59", "open_timestamp": 1635263039675, "story_date": "2021-06-23 00:00:00", "story_source": "tpl", "story_title": "Challenges expected for Novavax' COVID-19 vaccine in USA", "summary": "Novavax  is testing a new vaccine, the results are promising .It works against the main variant of covid, and also some other variants", "task_condition": "text", "task_key": "challenges-expected-for-novavax-covid-19-vaccine-in-usa", "task_level": "post_graduate_phd", "time_taken_in_seconds": 245630, "what": "about a new vaccine ", "when_happened": "current_month", "where_location": "United States", "who": "Ms Jaser  from Novavax ", "why": "contributes to fighting covid"}, "australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19": {"story_link": "https://www.thepharmaletter.com/article/australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19", "user_code": "SAP_3", "age_group": "51_plus", "agreed": true, "close_date_time": "2021-9-26 16:43:51", "close_timestamp": 1635263031926, "created": "26/10/2021 15:41:31", "department": "computing", "disability": false, "ease": 4, "environment": "production", "experiment_date_datepicker": "2021-10-26", "gender": "female", "id": "9b43bf6e-edf6-47a3-989a-d1cf1a04dcc8", "open_date_time": "2021-9-26 16:40:2", "open_timestamp": 1635262802694, "story_date": "2020-08-20 00:00:00", "story_source": "tpl", "story_title": "Australian GPs urged to prescribe ivermectin triple therapy to fight COVID-19", "summary": "Dr Wagstaff's team showed that already approved drugs, that can be prescribed by GPs, ca help fighting covid-19", "task_condition": "text", "task_key": "australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19", "task_level": "post_graduate_phd", "time_taken_in_seconds": 229232, "what": "already approved drugs that can be prescribed by GPs, can help fighting covid-19", "when_happened": "few_years_ago", "where_location": "Australia", "who": "Professor Borody", "why": "contributes to fighting covid"}, "japan-is-first-country-to-approve-covid-19-cocktail-ronapreve": {"story_link": "https://www.thepharmaletter.com/article/japan-is-first-country-to-approve-covid-19-cocktail-ronapreve", "user_code": "SAP_3", "age_group": "51_plus", "agreed": true, "close_date_time": "2021-9-26 16:34:51", "close_timestamp": 1635262491531, "created": "26/10/2021 15:32:33", "department": "computing", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-10-26", "gender": "female", "id": "d28d61e4-01e2-4da2-9c34-e55f3eaa6e5e", "open_date_time": "2021-9-26 16:30:59", "open_timestamp": 1635262259915, "story_date": "2020-07-21 00:00:00", "story_source": "tpl", "story_title": "Japan is first country to approve COVID-19 cocktail Ronapreve", "summary": "in Japan, later this year, it has been reported that Japan has approved a cocktail of drugs to fight covid-19", "task_condition": "viz", "task_key": "japan-is-first-country-to-approve-covid-19-cocktail-ronapreve", "task_level": "post_graduate_phd", "time_taken_in_seconds": 231616, "what": "approving a cocktail of drugs against covid 19", "when_happened": "current_month", "where_location": "Japan", "who": "Osami Okuda", "why": "contributes to fighting covid"}}, "tb": {"pfizer": {"story_term": "pfizer", "user_code": "SAP_3", "age_group": "51_plus", "agreed": true, "close_date_time": "2021-9-26 17:11:9", "close_timestamp": 1635264669191, "created": "26/10/2021 16:08:50", "department": "computing", "disability": false, "ease": 4, "environment": "production", "experiment_date_datepicker": "2021-10-26", "gender": "female", "id": "40c75e15-2096-402f-859a-4a2282b36495", "open_date_time": "2021-9-26 17:1:20", "open_timestamp": 1635264080860, "summary": "The pharmaceutical giant Pfizer has signed agreements with several other companies from Germany, Russia, China to work on the development and delivering vaccines against covid-19. The trial results showed that the vaccine is effective against the main variant and also other strains . There is a version of the vaccine for children. \r\n\r\nThe vaccine is being produced in huge quantities for the supplies in many countries. The revenue of the company is high, there is also substantial support from the authorities.\r\n\r\nPfizer did not stop development of other drugs, for other diseases. ", "task_condition": "text", "task_key": "pfizer", "task_level": "post_graduate_phd", "time_taken_in_seconds": 588331}, "astrazeneca": {"story_term": "astrazeneca", "user_code": "SAP_3", "age_group": "51_plus", "agreed": true, "close_date_time": "2021-9-26 16:56:2", "close_timestamp": 1635263762735, "created": "26/10/2021 15:53:44", "department": "computing", "disability": false, "ease": 2, "environment": "production", "experiment_date_datepicker": "2021-10-26", "gender": "female", "id": "7e5f9b4a-343c-46b0-9957-855bca81dc14", "open_date_time": "2021-9-26 16:48:12", "open_timestamp": 1635263292600, "summary": "Astrazenica vaccines are used, not only in European countries, but also wider, e.g. in Russian and China. The reported results are mostly positive, there is substantial support from the public and authorities for using Astrazenica vaccines. Benefits of vaccination are important, there is trust in the vaccination programme. However, there are also concerns associated with inevitable risks, cases of death, ability to work against other strains and possible connection with the increase of the risk of developing cancer.", "task_condition": "viz", "task_key": "astrazeneca", "task_level": "post_graduate_phd", "time_taken_in_seconds": 470135}}}